HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

You Wang Selected Research

Necrosis

1/2021OTULIN is a new target of EA treatment in the alleviation of brain injury and glial cell activation via suppression of the NF-κB signalling pathway in acute ischaemic stroke rats.
9/2008[Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma].
12/2007[Expression and significance of NET-1 protein in hepatocellular carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


You Wang Research Topics

Disease

56Neoplasms (Cancer)
04/2024 - 12/2007
12Infections
09/2023 - 01/2018
9Hepatocellular Carcinoma (Hepatoma)
06/2014 - 12/2007
8Neoplasm Metastasis (Metastasis)
01/2024 - 09/2008
6Inflammation (Inflammations)
01/2024 - 01/2017
6Mitochondrial Diseases (Mitochondrial Disease)
06/2023 - 11/2016
6Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2011
6Pain (Aches)
01/2022 - 01/2016
6Stomach Neoplasms (Stomach Cancer)
01/2020 - 10/2010
5Seizures (Absence Seizure)
03/2024 - 11/2020
5Type 2 Diabetes Mellitus (MODY)
01/2024 - 11/2019
5Epilepsy (Aura)
11/2023 - 11/2020
5Ischemic Stroke
08/2023 - 01/2021
5Stroke (Strokes)
08/2023 - 12/2020
5Hypoxia (Hypoxemia)
01/2020 - 06/2004
4Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 06/2016
4COVID-19
02/2024 - 08/2020
4Myocardial Infarction
10/2022 - 03/2005
3Temporal Lobe Epilepsy
11/2023 - 01/2020
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2023 - 01/2022
3Autoimmune Diseases (Autoimmune Disease)
06/2023 - 05/2019
3Starvation
06/2023 - 10/2015
3Propionic Acidemia
01/2023 - 11/2021
3Glioma (Gliomas)
10/2022 - 12/2012
3Osteolysis
05/2022 - 04/2015
3Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 12/2017
3Hypertension (High Blood Pressure)
11/2021 - 02/2007
3Necrosis
01/2021 - 12/2007
3Carcinogenesis
01/2021 - 11/2010
3Infarction (Infarctions)
01/2020 - 03/2005
3Body Weight (Weight, Body)
01/2020 - 06/2004
3Osteoarthritis
04/2019 - 05/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 04/2015
3Ovarian Epithelial Carcinoma
02/2014 - 07/2009
2Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2024 - 01/2023
2Embolic Stroke
08/2023 - 01/2021
2Familial Exudative Vitreoretinopathies
01/2023 - 01/2023
2Colonic Neoplasms (Colon Cancer)
10/2022 - 12/2020
2Osteoporosis
05/2021 - 02/2007

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
01/2024 - 11/2005
8Glucose (Dextrose)FDA LinkGeneric
06/2023 - 01/2016
6polyetheretherketoneIBA
09/2023 - 01/2018
6Biomarkers (Surrogate Marker)IBA
05/2023 - 06/2014
6Mitochondrial DNA (mtDNA)IBA
02/2023 - 06/2014
5Therapeutic UsesIBA
02/2024 - 12/2019
5Carrier Proteins (Binding Protein)IBA
06/2014 - 03/2008
4EnzymesIBA
01/2023 - 01/2017
4Antimicrobial PeptidesIBA
05/2022 - 11/2020
41-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2020 - 01/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2024 - 01/2019
3AntioxidantsIBA
04/2024 - 02/2018
3Kainic Acid (Kainate)IBA
03/2024 - 01/2022
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2023 - 12/2020
3Retinaldehyde (Retinal)IBA
01/2023 - 01/2022
3Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 05/2022
3Photosensitizing Agents (Photosensitizers)IBA
03/2022 - 02/2016
3Polyethylene (Polythene)IBA
01/2022 - 01/2018
3Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 - 11/2015
3Phosphotransferases (Kinase)IBA
11/2020 - 01/2013
3UbiquitinIBA
01/2018 - 11/2014
3Messenger RNA (mRNA)IBA
11/2014 - 11/2005
3ParaffinIBA
05/2013 - 12/2007
3Arsenic Trioxide (Trisenox)FDA Link
05/2010 - 12/2007
2Immune Checkpoint InhibitorsIBA
05/2024 - 01/2024
2Free RadicalsIBA
02/2024 - 11/2020
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2024 - 01/2020
2LigandsIBA
11/2023 - 12/2010
2AntibodiesIBA
11/2023 - 05/2019
2VaccinesIBA
10/2023 - 01/2023
2polydopamineIBA
09/2023 - 11/2020
2Immunoglobulin G (IgG)IBA
06/2023 - 06/2020
2Adenosine Triphosphate (ATP)IBA
06/2023 - 01/2017
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2023 - 08/2019
2AcidsIBA
06/2023 - 01/2021
2Metformin (Glucophage)FDA LinkGeneric
02/2023 - 01/2023
2AcarboseFDA LinkGeneric
02/2023 - 01/2023
26-propylchromone-2-carboxylic acid (PCCA)IBA
01/2023 - 11/2021
2propionyl-coenzyme A (propionyl-CoA)IBA
01/2023 - 11/2021
2Propionyl-Coenzyme A Carboxylase (Propionyl CoA Carboxylase)IBA
01/2023 - 11/2021
2KetonesIBA
10/2022 - 01/2018
2Biocompatible Materials (Biomaterials)IBA
08/2022 - 01/2018
2Annexin A2 (Annexin II)IBA
01/2022 - 01/2018
2Glucose OxidaseIBA
12/2021 - 08/2019
2Anticardiolipin AntibodiesIBA
11/2021 - 11/2020
2Immunoglobulin M (IgM)IBA
11/2021 - 11/2020
2Serine (L-Serine)FDA Link
10/2021 - 02/2014
2Cell-Penetrating PeptidesIBA
08/2021 - 12/2020

Therapy/Procedure

22Therapeutics
04/2024 - 01/2009
12Drug Therapy (Chemotherapy)
01/2024 - 11/2011
5Lasers (Laser)
05/2023 - 12/2007
4Prostheses and Implants (Prosthesis)
05/2022 - 01/2018
4Knee Replacement Arthroplasty (Total Knee Replacement)
01/2022 - 06/2010
3Radiotherapy
01/2020 - 01/2017
3Photochemotherapy (Photodynamic Therapy)
07/2019 - 01/2015
2Neoadjuvant Therapy
04/2024 - 01/2021
2Immunotherapy
01/2024 - 12/2020
2Aftercare (After-Treatment)
01/2024 - 01/2024
2Thrombectomy
08/2023 - 01/2021
2Arthroplasty
05/2022 - 01/2020
2Length of Stay
11/2021 - 01/2020